Advertisement

FDA approves first U-500 insulin pen device

Share This Page
FDA has cleared the first prefilled pen device containing concentrated U-500 strength insulin (Humulin R U-500 KwikPen—Eli Lilly) for diabetes patients who require more than 200 units per day. The new device is a more convenient alternative to the current U-500 vial, which requires use of a syringe and dose conversions.

FDA has cleared the first prefilled pen device containing concentrated U-500 strength insulin (Humulin R U-500 KwikPen—Eli Lilly) for diabetes patients who require more than 200 units per day. The new device is a more convenient alternative to the current U-500 vial, which requires use of a syringe and dose conversions. "The U-500 KwikPen was specifically designed as a dedicated dosing device to eliminate the need for dose conversion, as compared with use of the vial and syringe options, which some people may find to be an improvement," said Kevin Cammack, a senior marketing director at Lilly Diabetes. Each KwikPen holds 1500 units of insulin, the amount contained in five U-100 insulin pens, but is the same size as other Lilly KwikPens and dials in five-unit increments.

Ad Position: 
Bottom Center Aligned
http://www.medscape.com/viewarticle/857811

Advertisement

Related Content

block-views-related-content-block